Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Plos One|August 17, 2013
Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodesEvan S Weitman, Seth Z Aschen, Gina Farias-Eisner, et al.Cancer Chemotherapy and Pharmacology|July 21, 1999
Activity of the multitargeted antifolate LY231514 in the human tumor cloning assayC D Britten, E Izbicka, S Hilsenbeck, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
A Phase I trial of bryostatin-1 in children with refractory solid tumors: a Pediatric Oncology Group studyS Weitman, A M Langevin, R L Berkow, et al.Cancer Research|March 10, 1999
Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft modelC D Britten, S G Hilsenbeck, S G Eckhardt, et al.European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft modelL A Hammond, S G Hilsenbeck, S G Eckhardt, et al.Cancer Research|July 23, 1999
Water soluble 20(S)-glycinate esters of 10,11-methylenedioxycamptothecins are highly active against human breast cancer xenograftsR M Wadkins, P M Potter, B Vladu, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|June 8, 2001
Biodegradable block copolymers for delivery of proteins and water-insoluble drugsG M Zentner, R Rathi, C Shih, et al.Melanoma Research|December 21, 2017
Quality of life patient-reported outcomes for locally advanced cutaneous melanomaEvan S Weitman, Matthew Perez, John F Thompson, et al.Cancer Chemotherapy and Pharmacology|May 19, 2010
Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumorsF Caponigro, D Lorusso, G Fornari, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
Squalamine treatment of human tumors in nu/nu mice enhances platinum-based chemotherapiesJ I Williams, S Weitman, C M Gonzalez, et al.Pageof 4